Abstract:OBJECTIVE:To investigate the effect of small interfering RNA (siRNA) targeting human vascular endothelial growth factor (hVEGF) on A549 cell growth in nude mice and angiogenesis on chorioallantoic membrane (CAM) assay.METHODS:Three pairs of hVEGF siRNA-plasmid and non-silencing-plasmid were constructed, and transfected into A549 cells through lipofectamine 2000, respectively. The most effective pair of hVEGF siRNA-plasmid was selected by ELISA and real-time RT-PCR. A549 cells transfected with selected hVEGF siRNA- plasmid, A549 cells transfected with non-silencing-plasmid and A549 cells without transfection were inoculated into nude mice, respectively. Chick embryos were randomly divided into four groups and CAM was treated by different solutions for 48 h: culture media DMEM as negative control group,un-transfected A549 cell culture supernatants as positive control group, hVEGF siRNA A549 cell culture supernatants as hVEGF siRNA group and nonsilencing siRNA A549 cell culture supernatants as non-silencing siRNA group. The CAMs were harvested on d12 for microscopic assays.RESULT:Compared with control group, hVEGF siRNA-plasmid induced 48% reduction in hVEGF secretion by A549 cells accompanied by 70% reduction in hVEGF mRNA. Compared with non-silencing siRNA group, the mean tumor volume of murine xenograft was reduced by 58% in hVEGF siRNA group; time for xenografts growing to 50 mm(3)was delayed by 5.4 d. hVEGF contents in xenograft were reduced by 54%; but mean doubling time of tumors and the growth rate of tumors were not significantly reduced. In CAM assays, hVEGF content was zero in negative group, and in hVEGF siRNA group that was 40%-44% of non-silencing siRNA group or positive group; vessels branch points of CAM in hVEGF siRNA group or non-silencing siRNA group or positive group were increased by 45%-55% compared with negative group; total vessel length of CAM in hVEGF siRNA group was increased by 53% compared with negative group, while in non-silencing siRNA group or positive group that was increased by 97% or 99%. Compared with negative control group, the proliferation of microvessels was increased when cell culture supernatant with hVEGF was added in hVEGF siRNA group, significant proliferated vessels were observed in non-silencing siRNA group or positive group.CONCLUSION:A plasmid-mediated hVEGF siRNA has been constructed and verified, which can effectively downregulate the expression of hVEGF in human A549 cells, resulting in the inhibition of angiogenesis. hVEGF siRNA can delay initial growth of A549 tumor xenograft but not reduce the growth rate.

The Inhibition of 20(R)-Ginsenoside Rg3 on the Expressions of Angiogenesis Factors Proteins in Human Lung Adenocarcinoma Cell Line A549 and HUVEC304 Cell

[The Effect of 20(R)-Ginsenoside Rg3 on the Differential Expression of Cell Signaling Genes and Other Related Genes in Human Lung Adenocarcinoma Cell Line A549].

[The Effects of 20(R)-Rg3 on Lung Carcinoma A549 Cell Line and Endogenous VEGF Secreted by Tumor Cells].

[Antiangiogenesis of Ginsenoside Rg3 in Severe Combined Immunodeficient Mice with Human Ovarian Carcinoma].

Anti-proliferation and Chemo-Sensitization Effects of Apigenin on Human Lung Cancer Cells

The experimental study of ginsenoside Rg3 inhibiting angiogenesis induced by tumor cells

Effects of Autocrine Vascular Endothelial Growth Factor (VEGF) in Non-Small Cell Lung Cancer Cell Line A549.

THE CLINICAL EVALUATION OF ANGIOGENESIS INHIBITOR-20（R）-GINSENOSIDE RG 3 IN LUNG CANCER

Hvegf Sirna Inhibits Initial Growth of A549 Tumor Cells in Nude Mice and Angiogenesis on CAM Assay

Ginsenoside Rg3 Inhibits CXCR4 Expression and Related Migrations in a Breast Cancer Cell Line.

[Effect of Ginsenoside on the Cellular Proliferation, Apoptosis and Cell Cycles in LC A549 and HUVEC 304 Cell Lines].

The experimental study of ginsenoside Rg3 on inhibiting angiogenesis

Inhibitory Effects of 20 (S)-Ginsenoside Rg3 on Ovarian Cancer Growth

Tumor Suppression Activity of Ginsenoside Rg3 Combined with TRAIL Gene on Human Colon Cancer Cell Line HCE8693

Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells

Investigation of Targeting Relationship Between Micro-Rna-22 and Vegfr3 in Lung Squamous Cell Carcinoma

Anti-angiogenic Effect of Ginsenoside Rg3 in Nude Mice Cervical Cancer

Ginsenoside Rg3 to Regulate the EMT Induced by TGF-in Gastric Cancer.

Human Id3 Expression in Lung Adenocarcinoma Cell Line A549 and Its Inhibiory Effect on Cell Growth

Effects of Ginsenoside Rg3 on Growth and Apoptosis of Gastric Cancer Cell Lines in Vitro

Ginsenoside 20(S)-Rg3 Hinders Esophageal Squamous Cell Carcinoma Cells Malignant Behaviors by miR-210-3p/B4GALT5 Axis